Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Multilevel factors associated with length of stay for neonatal abstinence syndrome in Florida’s NICUs: 2010–2015

Abstract

Objective

To investigate potential factors influencing initial length of hospital stay (LOS) for infants with neonatal abstinence syndrome (NAS) in Florida.

Methods

The study population included 2984 term, singleton live births in 33 Florida hospitals. We used hierarchical linear modeling to evaluate the association of community, hospital, and individual factors with LOS.

Results

The average LOS of infants diagnosed with NAS varied significantly across hospitals. Individual-level factors associated with increased LOS for NAS included event year (P < 0.001), gestational age at birth (P < 0.001), maternal age (P = 0.002), maternal race and ethnicity (P < 0.001), maternal education (P = 0.032), and prenatal care adequacy (P < 0.001). Average annual hospital NAS volume (P = 0.022) was a significant hospital factor.

Conclusion

NAS varies widely across hospitals in Florida. In addition to focusing on treatment regimens, to reduce LOS, public health and quality improvement initiatives should identify and adopt strategies that can minimize the prevalence and impact of these contributing factors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flow diagram of infants with NAS included in the study.
Fig. 2: Variability of neonatal abstinence syndrome length of stay by hospitals in Florida: 2010–2015.
Fig. 3: Length of stay for neonatal abstinence syndrome by birth year.

Similar content being viewed by others

References

  1. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics. 2012;129:e540–60.

    Article  Google Scholar 

  2. Harper RG, Solish GI, Purow HM, Sang E, Panepinto WC. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants. Pediatrics. 1974;54:300–5.

    CAS  PubMed  Google Scholar 

  3. Fricker HS. Narcotic addiction, pregnancy, and the newborn. Am J Dis Child. 1978;132:360.

    CAS  PubMed  Google Scholar 

  4. Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol. 1977;127:199–201.

    Article  CAS  Google Scholar 

  5. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr. 1976;88:642–5.

    Article  CAS  Google Scholar 

  6. Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004–2014. Pediatrics. 2018;141.

  7. Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence syndrome—28 States, 1999–2013. Morb Mortal Wkly Rep. 2016;65:799–802.

    Article  Google Scholar 

  8. Patrick SW, Davis MM, Lehmann CU, Cooper WO, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35:650–5.

    Article  CAS  Google Scholar 

  9. McQueen K, Murphy-Oikonen J. Neonatal Abstinence Syndrome. Longo DL, editor. N Engl J Med. 2016;375:2468–79.

  10. Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing Incidence of the Neonatal Abstinence Syndrome in U.S. Neonatal ICUs. N Engl J Med. 2015;372:2118–26.

    Article  Google Scholar 

  11. Cleary BJ, Donnelly JM, Strawbridge JD, Gallagher PJ, Fahey T, White MJ, et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2011;204:139.e1–9.

    Article  Google Scholar 

  12. Lee J, Hulman S, Musci M, Stang E. Neonatal abstinence syndrome: influence of a combined inpatient/outpatient methadone treatment regimen on the average length of stay of a Medicaid NICU population. Popul Health Manag. 2015;18:392–7.

    Article  Google Scholar 

  13. Tolia VN, Murthy K, Bennett MM, Greenberg RG, Benjamin DK, Smith PB, et al. Morphine vs methadone treatment for infants with neonatal abstinence syndrome. J Pediatr. 2018;203:185–9.

    Article  CAS  Google Scholar 

  14. Brown MS, Hayes MJ, Thornton LM. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol. 2015;35:278–83.

    Article  CAS  Google Scholar 

  15. Patrick SW, Kaplan HC, Passarella M, Davis MM, Lorch SA. Variation in treatment of neonatal abstinence syndrome in US children’s hospitals, 2004–2011. J Perinatol. 2014;34:867–72.

    Article  CAS  Google Scholar 

  16. Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014;134:e527–34.

    Article  Google Scholar 

  17. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA. 2012;307:1934–40.

    Article  CAS  Google Scholar 

  18. Corr TE, Hollenbeak CS. The economic burden of neonatal abstinence syndrome in the United States. Addiction. 2017;112:1590–9.

    Article  Google Scholar 

  19. Hekman KA, Grigorescu VI, Cameron LL, Miller CE, Smith RA. Neonatal withdrawal syndrome, Michigan, 2000–2009. Am J Prev Med. 2013;45:113–7.

    Article  Google Scholar 

  20. Grisham LM, Stephen MM, Coykendall MR, Kane MF, Maurer JA, Bader MY. Eat, sleep, console approach: a family-centered model for the treatment of neonatal abstinence syndrome. Adv Neonatal Care. 2019;19:138–44.

    Article  Google Scholar 

  21. Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK. A novel approach to assessing infants with neonatal abstinence syndrome. Hosp Pediatr. 2018;8:1–6.

    Article  Google Scholar 

  22. Kotelchuck M. An evaluation of the Kessner adequacy of prenatal care index and a proposed adequacy of prenatal care utilization index. Am J Public Health. 1994;84:1414–20.

    Article  CAS  Google Scholar 

  23. Florida Department of Health. FLHealthCHARTS—birth query system. 2019. http://www.flhealthcharts.com/FLQUERY/Birth/BirthRpt.aspx.

  24. Ko JY, Wolicki S, Barfield WD, Patrick SW, Broussard CS, Yonkers KA, et al. CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome. Morb Mortal Wkly Rep. 2017;66:242–5.

    Article  Google Scholar 

  25. Florida Department of Health. E-FORCSE Home Page. 2019. http://www.floridahealth.gov/statistics-and-data/e-forcse/.

  26. ACOG Committee on Health Care for Underserved Women; American Society of Addiction Medicine. ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012;119:1070–6.

    Article  Google Scholar 

  27. Substance Abuse and Mental Health Services Administration. Federal guidelines for opioid treatment programs. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP. 2015. http://store.samhsa.gov.

  28. Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, et al. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018;38:1114–22.

    Article  Google Scholar 

  29. Krans EE, Cochran G, Bogen DL. Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations. Clin Obstet Gynecol. 2015;58:370–9.

    Article  Google Scholar 

  30. Jutte DP, Roos LL, Brownell MD. Administrative record linkage as a tool for public health research. Annu Rev Public Health. 2011;32:91–108.

    Article  Google Scholar 

Download references

Funding

This study was partially supported by a contract from the Florida Department of Health.

Author information

Authors and Affiliations

Authors

Contributions

All authors conceptualized and designed the study. CNR, and TRF conducted data analysis. CNR drafted the initial manuscript and received critical input from TRF, AKM, MLH, MB, RSK, REW, and WMS in the final manuscript.

Corresponding author

Correspondence to Chinyere N. Reid.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reid, C.N., Foti, T.R., Mbah, A.K. et al. Multilevel factors associated with length of stay for neonatal abstinence syndrome in Florida’s NICUs: 2010–2015. J Perinatol 41, 1389–1396 (2021). https://doi.org/10.1038/s41372-020-00815-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41372-020-00815-8

This article is cited by

Search

Quick links